Extended Perioperative Administration of Fibrinolysis Inhibitors After Cardiac Surgery

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2024
PRIORITY is a pragmatic, multi-center, cluster crossover trial that aims to evaluate whether implementing a policy of routine extended (intraoperative and 4 hour after transfer to ICU) use of fibrinolysis inhibitors leads to a decrease in post-operative blood transfusion compared to a policy that only involves intraoperative use.
Epistemonikos ID: 7b6a220fab997e931fc319d980e9bab3102a94f9
First added on: Apr 17, 2025